July 3 (Reuters) - U.S. private equity firm Carlyle Group CG.O is preparing to offload up to a 10% stake in India's Piramal Pharma PIRM.NS through block trades, online news portal Moneycontrol reported on Thursday, citing sources.
The U.S.-based private equity firm could earn in the range of 26 billion rupees ($304.8 million) to 27 billion rupees from the sale, the report added.
($1 = 85.3090 Indian rupees)
(Reporting by Hritam Mukherjee in Bengaluru; Editing by Nivedita Bhattacharjee)
((Hritam.Mukherjee@thomsonreuters.com; X: @MukherjeeHritam;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.